Business

Immutep to Participate in Upcoming Investor Conferences

SYDNEY, AUSTRALIA , April 02, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces its management will present and participate in one-on-one meetings at the following investor conferences: Jones Healthcare and Technology Innovation Conference Location:Las Vegas, NV Date: Wednesday, 9 April 2025 Time:4:30 pm ET The Citizens Life Sciences ConferenceLocation:New Yo

articleImmutep LtdApril 2, 20251/company/immutep-ltd/news/immutep-participate-upcoming-investor-conferences-120000160
Immutep to Participate in Upcoming Investor Conferences

About this update from Immutep Ltd

[{"type":"image","alt":"Immutep Limited","displaySize":"","headline":null,"caption":"Immutep Limited","className":"","disableSlideshowImg":false,"size":{"original":{"width":246,"height":103,"url":"https://media.zenfs.com/en/globenewswire.com/60325dae98d9e851c4236017024da578"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/PIIfOSI4irhaeByOTtn6bg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE3NjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/60325dae98d9e851c4236017024da578","width":246,"height":103}},"lazy":false},{"type":"text","content":"SYDNEY, AUSTRALIA , April 02, 2025 (GLOBE NEWSWIRE) --  Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces its management will present and participate in one-on-one meetings at the following investor conferences:","length":330,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"width:10%;text-align:justify;vertical-align:middle;vertical-align:middle;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":" ","length":6,"tagName":"p"}]}]},{"val":[{"colspan":"2","style":"text-align:justify;vertical-align:middle;vertical-align:middle;","val":[{"type":"text","content":"Jones Healthcare and Technology Innovation Conference","length":53,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":" ","length":6,"tagName":"p"}]}]},{"val":[{"style":"text-align:justify;vertical-align:middle;vertical-align:middle;","val":[{"type":"text","content":"Location:","length":9,"tagName":"p","attribs":{}}]},{"style":"text-align:justify;vertical-align:middle;vertical-align:middle;","val":[{"type":"text","content":"Las Vegas, NV","length":13,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":" ","length":6,"tagName":"p"}]}]},{"val":[{"style":"text-align:justify;vertical-align:middle;vertical-align:middle;","val":[{"type":"text","content":"Date:","length":5,"tagName":"p","attribs":{}}]},{"style":"text-align:justify;vertical-align:middle;vertical-align:middle;","val":[{"type":"text","content":"Wednesday, 9 April 2025","length":23,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":" ","length":6,"tagName":"p"}]}]},{"val":[{"style":"text-align:justify;vertical-align:middle;vertical-align:middle;","...

More updates from Immutep Ltd

immunotherapy companyImmutepautoimmune diseases